Article info
PDFPancreas
Original research
Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer
- Correspondence to Erik S Knudsen, Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA; erik.knudsen{at}roswellpark.org; Dr Agnieszka K Witkiewicz, Center for Precision Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA; Agnieszka.Witkiewicz{at}roswellpark.org
Citation
Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer
Publication history
- Received February 27, 2020
- Revised March 30, 2020
- Accepted April 19, 2020
- First published May 18, 2020.
Online issue publication
February 19, 2021
Article Versions
- Previous version (19 February 2021).
- Previous version (19 February 2021).
- Previous version (19 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.